Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ESBL Producing E.Coli”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Not applicableStudy completedNCT00167986
What this trial is testing

Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care

Who this might be right for
Escherichia Coli InfectionsKlebsiella Infections
Wyeth is now a wholly owned subsidiary of Pfizer 480
Large-scale testing (Phase 3)UnknownNCT00300560
What this trial is testing

Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli

Who this might be right for
Infections
Mahidol University 152
Not applicableEnded earlyNCT04323553
What this trial is testing

Comparison of Pulsed-field Gel Electrophoresis and Whole Genome Sequencing to Determine Transmission Rate of ESBL-producing E.Coli

Who this might be right for
Analysis Transmission Rate
University Hospital, Basel, Switzerland 43
Not applicableStudy completedNCT01324726
What this trial is testing

Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms

Who this might be right for
Escherichia Coli InfectionsKlebsiella Pneumonia
American University of Beirut Medical Center 100
Not applicableEnded earlyNCT01820793
What this trial is testing

Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli

Who this might be right for
Acute Pyelonephritis Without Severity Symptoms Due to ESBL-producing E.Coli
Assistance Publique - Hôpitaux de Paris 9
Post-approval studies (Phase 4)Ended earlyNCT02474706
What this trial is testing

Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli

Who this might be right for
Urinary Tract Infections
Central Hospital, Nancy, France 6
Not applicableStudy completedNCT00573235
What this trial is testing

Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli

Who this might be right for
Enterobacteriaceae Infections
University of Pittsburgh 300
Not applicableUnknownNCT03343119
What this trial is testing

Epidemiology of Resistant Microbial Strains Among Different Groups of People (Healthy, Infected and Exposed to Animals)

Who this might be right for
ESBL Producing E.ColiESBL Producing K.PneumoniaeMultidrug Resistant P.Aeruginosa+3 more
University of Tartu 708
Not applicableStudy completedNCT00167999
What this trial is testing

Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units

Who this might be right for
Gram-Positive Bacterial InfectionsEscherichia Coli InfectionsKlebsiella Infections
Wyeth is now a wholly owned subsidiary of Pfizer 200
Not applicableUnknownNCT02456818
What this trial is testing

Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards

Who this might be right for
Oncology [See Also, Affected System]Hematological DiseaseInfection Due to ESBL Escherichia Coli
University of Cologne 2,264
Not applicableStudy completedNCT01961206
What this trial is testing

Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis

Who this might be right for
Community Acquired Infection
Jian-cang Zhou M.D. 960
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07318584
What this trial is testing

Cefotetan Therapy for Escherichia Coli Infections

Who this might be right for
E Coli InfectionESBL Producing E.Coli
Oregon Health and Science University 84
Post-approval studies (Phase 4)Temporarily pausedNCT03891433
What this trial is testing

Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae

Who this might be right for
Urinary Tract InfectionsEnterobacteriaceae InfectionsInfection Due to ESBL Bacteria+5 more
Universidad del Norte 198
Not applicableActive Not RecruitingNCT04764500
What this trial is testing

Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

Who this might be right for
Extended Spectrum Beta Lactamases (ESBL) E. Coli
University Hospital, Basel, Switzerland 39